| 000 | 01570 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514024737.0 | ||
| 264 | 0 | _c20020604 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.2002.01199.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMalchow, H | |
| 245 | 0 | 0 |
_aA new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cMar 2002 |
||
| 300 |
_a415-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 | _aDosage Forms |
| 650 | 0 | 4 | _aEndoscopy, Gastrointestinal |
| 650 | 0 | 4 |
_aEnema _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesalamine _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGertz, B | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 16 _gno. 3 _gp. 415-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.2002.01199.x _zAvailable from publisher's website |
| 999 |
_c11783855 _d11783855 |
||